STAT3 and T-cell large granular lymphocyte leukemia: We described our real-life experience (clinical features, response to therapy, impact of STAT3 mutations and outcome) of 131 unselected patients with T-LGLL and CLPD-NK diagnosed and followed up at a single institution.